Table 1 Comparison of baseline clinical characteristics between the ESR-C and ESR-EB groups.
ESR-C, n = 29 | ESR-EB, n = 35 | t/χ2 | P value | |
---|---|---|---|---|
Age (years) | 52.83 ± 10.24 | 52.77 ± 8.46 | 0.024 | 0.981 |
gender, n (%) | 0.620 | 0.427 | ||
Male | 11 (37.93) | 10 (28.57) | ||
Female | 13 (62.07) | 25 (71.43) | ||
Location, n (%) | 2,518 | 0.472 | ||
Body | 14 (48.28) | 14 (40.00) | ||
Fundus | 14 (48.28) | 20 (57.14) | ||
Antrum | 0 (0.00) | 1 (2.86) | ||
Cardia | 1 (3.45) | 0 (0.00) | ||
Tumour size, mm | 6.47 ± 1.93 | 7.28 ± 1.78 | −1.742 | 0.086 |
Growth pattern, n (%) | 2.548 | 0.280 | ||
Intraluminal growth | 4 (13.79) | 2 (5.71) | ||
Extraluminal growth | 1 (3.45) | 0 (0.00) | ||
Mixed growth | 24 (82.76) | 33 (94.29) |